Healthcare Business Investment Opportunities

- It is a 100 bedded multi-speciality hospital. - The facility includes 2 OT, 1 ambulance, 10 in-house doctors, 2 ICUs. - Also have in-house CT Scan, X-Ray, USG, laboratory, dialysis. - Occupancy rate was 50-60% before the pandemic. - Good visibility and located close to a metro station. - Promoter has 3 years of industry experience.

- Our company was born with a vision to change the standard ways of homoeopathic treatment. - Patients can contact us around the clock to avail best advice from experienced homoeopathic doctors and related services. - Company enables our patients to access experienced doctors at the convenience of their homes through Zoom video calls. - At the moment, we have 5-6 registered doctors and 20-30 patients using our services. - Promoter is an alumnus of IIM Ahmedabad with experience in homoeopathic treatment. - We are doing online promotions and generating leads through Facebook and Instagram marketing. - We have hired an experienced company to develop a mobile app and portal for us and we require funds for that. - Company has equal partners who are husband and wife. - Business does not have any liabilities.

- We are producers of health & wellness products under our own registered trademark and sell through both B2B and D2C channels. - Have our own website and are listed on Amazon, Flipkart and other ecommerce platforms for D2C sales. - We generate 80% revenue from e-commerce and 20% revenue from the retail network. - In total, we have 30 SKUs and trademarks for the brand. - Our products are sold under our own brand name. - Brand and formulas were built from scratch, intellectual properties are transferrable. - Company is debt-free and has 4 directors with equal stake in the company. - Promoter has 6 years of experience in this field.

- Distributor of medical equipment and devices for hospitals in Andhra Pradesh and Telangana. - We procure the devices and equipment from 3 suppliers in the USA and Japan. - Authorized distributors for Instrumentation Laboratory Worldwide and Sysmex Corporation. - Distribute the equipment to around 120 hospitals. - We are looking to branch out to the export business for medical equipment and other industries including agriculture and FMCG. - Have secured 3 tenders worth INR 6 crore and we require funds for working capital. - Promoter has over 8 years of experience in medical equipment distribution. - Business owned assets include computers, furniture, and office equipment.

- Sold Ayurvedic products like slimming tablets, ayurvedic hair oil and specially blended shampoos. - Business paused operations about 1.5 to 2 years ago and is not operational currently. Require funds to restart operations and undertake marketing. - Introduced the slimming tablets brand in the market towards the end of 2016 and sold over INR 50 lakh worth of stock before the product was pulled from the shelves. After 1 year, the hair oil brand was launched. Sold INR 76 lakh worth of product over the product's life cycle. Alongside the hair oil, the Ayurvedic shampoos were also sold and they brought in around INR 5 - 8 lakh. Product was sold at a net margin of 25% and was launched in urban Telangana, Andhra Pradesh and Bengaluru. - Had tied up with a third party manufacturer for production. Manufacturer charged a commission on the sales of the Ayurvedic product as compensation. - A number of new products have been developed by the business that can be launched once funding is received. - Developed 2 high-quality television advertisements that were broadcasted on local Telugu and Kannada channels in south India. Tied up with popular Telugu actors to promote the product. Invested nearly INR 55 - 60 lakh into advertising. - Losses from the previous years can be carried forward and be adjusted against the profits to reduce the taxable income. - Owner has prior experience as the CEO of another Ayurvedic company. Introduced a hair oil brand in the market that was worth INR 100 crore while working at that company.

- We are an online B2C pharmacy platform dealing with generic medicines. - Directly source the medicines from company manufacturers and have tie-ups with 12 companies. - Our application is on the Play Store with 100,000+ installs. - On average, we get approx 200 orders daily and have tied up with our delivery partner. - The development and maintenance of the application are outsourced. - We plan to extend our services to the B2B sector as well in the coming month and have our warehouses in different states. - Sales have increased because of increased repeated customers and focus on marketing.

- We incorporated our startup both in Hyderabad, India five years back and in Foothill Ranch, California, USA one year ago. - Our co-founders are a team of 5 experienced PhDs and a medical doctor with clinical research experience in 3 multi-national pharma companies. We also have a woman co-founder (an Indian national) with an MMS degree. We have also hired an experienced auditor (in India) /CPA (in the USA) to help us in regulatory filings with respective government authorities. We also have an experienced business advisor (an Indian national). - Our co-founders have contributed >USD 108,000 so far. - Currently developing 3 new chemical entities (NCEs): Enhanced Naproxen (E-Naproxen), Enhanced irinotecan (E-Irinotecan), and Enhanced Aspirin (E-Aspirin) - Our initial focus is on the US market and we will bring our products to India and other major markets once we gain respectable sales figures in the US market. - Planning to develop these NCEs in the USA through the most economical (<USD 10 million) and shortest (<1.5–2.5 years) USFDA’s 505 (b) (2) regulatory route, which also grants 3-5 years exclusivity along with approval. - Currently, our NCEs are in the pre-clinical stage and will get all the regulatory approvals as per the requirement. - After securing the required funding (or equivalent amount in INR), we will take up the development of our first product. - Our startup was among the top 60 startups selected for acceleration under South Korea’s latest K-Startup Grand Challenge Program. Our CSO attended this acceleration program in Korea. - We have already obtained three patents (US, Canadian and Indian patents) on Enhanced Naproxen and Enhanced Aspirin and we will file provisional patent applications on Enhanced Irinotecan as soon as we secure the required seed funding.